With Market Size Valued at $6.6 Billion by 2026, it`s a Healthy Outlook for the Global Radiation Therapy Equipment Market
SAN FRANCISCO, March 1, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Radiation Therapy Equipment - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
What's New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
Edition: 18; Released: February 2022
Executive Pool: 2803
Companies: 54 - Players covered include Accuray Incorporated; BrainLab AG; Elekta AB; GE Healthcare; Hitachi America, Ltd.; IBA Group; Nordion, Inc.; Philips Healthcare; RaySearch Laboratories AB; Sumitomo Heavy Industries Ltd.; Varian Medical Systems, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Type (External Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy); End-Use (Hospitals, Other End-Uses)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
ABSTRACT-
Global Radiation Therapy Equipment Market to Reach US$6.6 Billion by the Year 2026
Radiation therapy or radiotherapy has emerged as an integral part of treatment for cancer patients. By using high-energy radiation from sources such as X-rays, neutrons, protons, and gamma rays, radiotherapy kills cancer-affected tissues or prevents multiplication of cancer cells in the body. Growth in the global market continues to be driven by the constant increase in the number of cancer patients across the world and the increasing adoption of radiation therapy for treatment of cancer. Advancing cancer treatment technologies and increasing availability of reimbursement coverage for radiotherapy treatments is expected to favor market growth. Also driving growth is the steadily expanding elderly population and rising incidence of cancer in this age group. Reducing cost of treatment in several developed nations, and increasing government and private investments in research and development associated with cancer treatment are fostering growth in the global radiotherapy equipment market. The recent advancements and innovations in the radiation therapy space have led to the development of effective treatments, a good prognosis, and reduced side effects during the treatment. There are significant developments observed in the areas of stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT), nanotechnology, 4D imaging, particle therapy, which are further improving the radiotherapy treatments. With the advances in the treatment protocols, there has been a surge in demand for automated products, which can be incorporated in the clinical practice systems.
Amid the COVID-19 crisis, the global market for Radiation Therapy Equipment estimated at US$5.5 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2026, growing at a CAGR of 4.3% over the analysis period. External Beam Radiation Therapy, one of the segments analyzed in the report, is projected to grow at a 4.5% CAGR to reach US$5.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Internal Radiation Therapy segment is readjusted to a revised 3.5% CAGR for the next 7-year period. This segment currently accounts for a 9.5% share of the global Radiation Therapy Equipment market. The external beam radiation therapy involves transmission of radiation through a machine that is placed outside the body. Incidence of cancer cases, and increasing patient and physician awareness about procedures, ongoing improvement in diagnostic techniques, and availability of advanced diagnostic techniques are driving segment growth. Internal radiation therapy, also termed as brachytherapy, involves placing radioactive material or implant through a catheter, at the tumor site and at surrounding tissue. Growth in the segment is led primarily by the expanding pool of cancer patients.
The U.S. Market is Estimated at $2 Billion in 2022, While China is Forecast to Reach $546.7 Million by 2026
The Radiation Therapy Equipment market in the U.S. is estimated at US$2 Billion in the year 2022. The country currently accounts for a 36.7% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$546.7 Million in the year 2026 trailing a CAGR of 5.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR while Rest of European market (as defined in the study) will reach US$583.3 Million by the end of the analysis period. Developed regions including the US, Canada, Japan and Europe represent the leading regional markets for radiotherapy equipment due largely to the presence of well-established and advanced healthcare infrastructure facilities and higher adoption of advanced radiation therapies for cancer treatment. In developing countries, growth will be driven by increasing incidence of cancer and the consequent growth in demand for cancer treatment techniques including radiation therapy.
Systemic Radiation Therapy Segment $401.7 Million by 2026
Systemic radiation therapy entails use of radioactive materials like iodine-131 or strontium-89 that travel through blood to eliminate cancerous cells. Systemic radiotherapy market is being driven by rapid changes in cancer treatment technologies and sustained increase in the number of cancer patients, worldwide. Growth is also being fueled by the technique's growing application in areas such as bone metastasis, thyroid cancer, non-Hodgkin's lymphoma and radio immunotherapy. In the global Systemic Radiation Therapy segment, USA, Canada, Japan, China and Europe will drive the 3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$283.4 Million will reach a projected size of US$349.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$37.9 Million by the year 2026, while Latin America will expand at a 3.9% CAGR through the analysis period. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]
LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter
https://twitter.com/marketbytes
Journalists & Media
[email protected]
SOURCE Global Industry Analysts, Inc.
Share this article